Broncho-Vaxom

Known as: broncho vaxom 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1954-2017
02419542016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
UNLABELLED The utilization of immunosuppressive agents presents patients with autoimmune nephrosis at a high risk of infection… (More)
Is this relevant?
2001
2001
This study was conducted to test the efficacy of Broncho-Vaxom (OM-85 BV) in rats after exposure to radiation-induced oxidative… (More)
Is this relevant?
1998
1998
We examined the in vitro effect of Broncho Vaxom (BV) (an immunobiotherapeutic preparation containing a lysate made from bacteria… (More)
Is this relevant?
1996
1996
The effects of the bacterial extract broncho-vaxom (BV; radioprotective immunomodulator; 500 micrograms/mouse i.p., -24 h) and… (More)
Is this relevant?
1995
1995
Possibilities of combined radioprotection, using preirradiation WR-2721 administration and post- or preirradiation Broncho-Vaxom… (More)
Is this relevant?
1994
1994
The possibilities of combined radioprotection, using preirradiation WR-2721 administration and post- or preirradiation Broncho… (More)
Is this relevant?
1990
1990
In 28 adult patients with nonobstructive chronic bronchitis we investigated components of the immune system of the lower airways… (More)
Is this relevant?
1989
1989
Forty-five symptomless "other Salmonella" carriers were treated; stool became negative for Salmonella in 22 of the 25 patients… (More)
Is this relevant?
1989
1989
Broncho-Vaxon (OM-85 BV) is a bacterial extract of eight bacterias usually involved in the respiratory tract infections. Since… (More)
Is this relevant?
1984
1984
The compensatory effect of a bacterial lysate, Broncho-Vaxom (BV) on the immunosuppressive action of cyclophosphamide (CY) was… (More)
Is this relevant?